You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 20, May 26, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (65)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Immunization
 •Bacterial Infections
 •Neurology
 •Alert me on articles by topic

Risk of Meningococcal Infection in College Students

Lee H. Harrison, MD; Diane M. Dwyer, MD; Charles T. Maples, MPH; Lillian Billmann, RN, MPH

JAMA. 1999;281:1906-1910.

Context  The number of meningococcal outbreaks on college campuses have been increasing in the past few years. However, no published studies have documented the incidence of invasive meningococcal infection in college students or whether the incidence is higher than in the general population of the same age.

Objective  To compare the incidence of invasive meningococcal infection in Maryland college students with that of the general population of the same age.

Design  Retrospective cohort study.

Setting and Patients  Maryland residents with meningococcal infection from 1992-1997 identified from active, laboratory-based, statewide surveillance for invasive meningococcal disease.

Main Outcome Measures  Incidence of invasive meningococcal infection.

Results  Of 228 patients with invasive meningococcal infection, 67 were aged 16 to 30 years; 11 and 3 of these attended Maryland 4- and 2-year colleges, respectively. Of these, 12 (86%) had infection caused by Neisseria meningitidis serogroups included in the current meningococcal vaccine. The average annual incidence was 1.74 per 100,000 among students in 4-year schools vs 1.44 per 100,000 for the general population of the same age (P=.60). Among students in 4-year schools, the incidence was 3.24 per 100,000 in on-campus residents vs 0.96 per 100,000 in off-campus residents (relative risk, 3.4; 95% confidence interval, 1.0-11.6; P=.05).

Conclusions  The incidence of meningococcal infection in college students is similar to the incidence in the general population of the same age, but college students residing on campus appear to be at higher risk than those residing off campus.


Author Affiliations: Department of International Health, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Md (Dr Harrison and Ms Billmann); Departments of Epidemiology and Medicine, University of Pittsburgh Graduate School of Public Health and School of Medicine, Pittsburgh, Pa (Dr Harrison); Epidemiology and Disease Control Program, Community and Public Health Administration, Maryland Department of Health and Mental Hygiene, Baltimore (Dr Dwyer); and Department of Epidemiology and Biostatistics, George Washington University School of Public Health and Health Services, Washington, DC (Mr Maples).


RELATED ARTICLE

May 26, 1999
JAMA. 1999;281(20):1959-1960.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Multicenter Surveillance of Invasive Meningococcal Infections in Children
Kaplan et al.
Pediatrics 2006;118:e979-e984.
ABSTRACT | FULL TEXT  

Diagnosing Meningococcal Disease
Schiff
AAP Grand Rounds 2006;15:56-57.
FULL TEXT  

Risk and protective factors for meningococcal disease in adolescents: matched cohort study
Tully et al.
BMJ 2006;332:445-450.
ABSTRACT | FULL TEXT  

Prospects for Vaccine Prevention of Meningococcal Infection
Harrison
Clin. Microbiol. Rev. 2006;19:142-164.
ABSTRACT | FULL TEXT  

Safety, Immunogenicity, and Immune Memory of a Novel Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MCV-4) in Healthy Adolescents
Keyserling et al.
Arch Pediatr Adolesc Med 2005;159:907-913.
ABSTRACT | FULL TEXT  

Prevention and Control of Meningococcal Disease: Recommendations for Use of Meningococcal Vaccines in Pediatric Patients
Committee on Infectious Diseases
Pediatrics 2005;116:496-505.
ABSTRACT | FULL TEXT  

Meningococcal Conjugate Vaccine in Adolescents and Children
Pichichero
CLIN PEDIATR 2005;44:479-489.
ABSTRACT  

Surface Plasmon Resonance Analysis of Antipolysaccharide Antibody Specificity: Responses to Meningococcal Group C Conjugate Vaccines and Bacteria
Garcia-Ojeda et al.
Infect. Immun. 2004;72:3451-3460.
ABSTRACT | FULL TEXT  

Active Immunization in the United States: Developments over the Past Decade
Dennehy
Clin. Microbiol. Rev. 2001;14:872-908.
ABSTRACT | FULL TEXT  

Risk Factors for Meningococcal Disease in College Students
Bruce et al.
JAMA 2001;286:688-693.
ABSTRACT | FULL TEXT  

Invasive Meningococcal Disease in Adolescents and Young Adults
Harrison et al.
JAMA 2001;286:694-699.
ABSTRACT | FULL TEXT  

Toward Control of Meningococcal Disease: Reducing Risk in College Students
Wenger
JAMA 2001;286:720-721.
FULL TEXT  

Meningococcal Disease Prevention and Control Strategies for Practice-Based Physicians (Addendum: Recommendations for College Students)
Committee on Infectious Diseases
Pediatrics 2000;106:1500-1504.
ABSTRACT | FULL TEXT  

Meningococcal Infection in College Students
Barton and Shulman
AAP Grand Rounds 1999;2:13-14.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.